MAIA Biotechnology, Inc.

MAIA

MAIA Biotechnology, Inc.

MAIA

Insider Sentiment (TTM):

Last Purchase:2026-06-01Last Sale:-Shares Purchased (TTM):491,052Shares Sold (TTM):0

Institutional Sentiment:

As of:2026-03-31Institutional Shares Owned:13,105,226Shares Outstanding:45,212,103Institutional Ownership Pct.:28.99%

Earnings Market Reaction:

Filing Date:2026-08-10Price on Filing Date:N/APrevious Close:N/A% Change:N/A

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Financial Statements

10‑Q10‑K

Values in Millions ($)	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30
Assets
Cash	28	34	9	11	10	11	10	9	12	8	7	6
Assets Current
Assets Current	28	35	10	12	11	12	10	9	12	9	8	7
Prepaid Expense And Other Assets Current	1	1	1	1	1	1	0	0	0	0	0	0
Deferred Costs	-	-	-	-	-	-	-	-	-	0	0	0
Other Assets Noncurrent	0	0	0	0	0	0	0	0	0	0	0	0
Assets	28	35	10	12	11	12	10	9	12	9	8	7
Liabilities And Stockhold…
Accounts Payable Current	3	3	2	3	2	2	2	1	1	2	2	1
Liabilities Current
Liabilities Current	6	6	6	10	5	5	4	4	4	5	5	4
Accrued Liabilities Current	3	3	4	7	3	3	2	2	2	3	3	3
Derivative Liabilities Noncurrent	1	1	1	2	2	-	3	-	-	-	-	-
Liabilities Noncurrent
Liabilities	8	8	7	12	7	7	7	8	9	14	7	4
Common Stock Value	0	0	0	0	0	0	0	0	0	0	0	0
Additional Paid In Capital	145	144	112	106	101	97	91	85	84	66	64	61
Stockholders Equity
Stockholders Equity	21	28	2	0	4	5	4	2	3	-6	0	3
Retained Earnings Accumulated Deficit	-124	-116	-110	-106	-97	-92	-87	-84	-81	-72	-64	-58
Accumulated Other Comprehensive Income Loss Net Of…	-0	-0	-0	-0	-0	-0	-0	-0	-0	-0	-0	-0
Liabilities And Stockholders Equity	28	35	10	12	11	12	10	9	12	9	8	7
Preferred Stock Par Or Stated Value Per Share	0	0	0	0	0	0	0	0	0	0	0	0
Preferred Stock Shares Authorized	30	30	30	30	30	30	30	30	30	30	30	30
Preferred Stock Shares Issued	0	0	0	0	0	0	0	0	0	0	0	0
Preferred Stock Shares Outstanding	0	0	0	0	0	0	0	0	0	0	0	0
Common Stock Par Or Stated Value Per Share	0	0	0	0	0	0	0	0	0	0	0	0
Common Stock Shares Authorized	150	150	150	150	150	70	70	70	70	70	70	70
Common Stock Shares Issued	61	61	39	34	32	30	26	24	24	21	17	14
Shares Outstanding	61	61	39	34	32	30	26	24	24	21	17	14

Subscribe to unlock 17+ years of financial data, unlimited metrics, and saved tables

Start 7-day free trial

Subscribe to unlock 17+ years of data, unlimited metrics, and saved tables

Start free trial

Custom Table

10‑Q10‑K

0/5

Search a metric to start building a table

Subscribe to unlock 17+ years of financial data, unlimited metrics, transformations, and saved visuals

Start 7-day free trial

Subscribe to unlock 17+ years of data, unlimited metrics, transformations, and saved visuals

Start free trial

Interactive Financial Visualizations

10‑Q10‑K

Stock Price:

OnOff

Transformations:

0/1

Search a metric to start building a visual

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Earnings Market Reaction

10‑Q10‑K

Fiscal Year	Q1 1 Month	Q1 2 Month	Q1 3 Month	Q2 1 Month	Q2 2 Month	Q2 3 Month	Q3 1 Month	Q3 2 Month	Q3 3 Month	Q4 1 Month	Q4 2 Month	Q4 3 Month
2026	3.82%	10.69%	-4.58%	-	-	-	-	-	-	-	-	-
2025	-12.25%	-13.24%	-16.67%	3.36%	16.11%	-16.78%	5.36%	40.18%	128.57%	-9.40%	-15.44%	-12.75%
2024	35.92%	17.25%	3.87%	14.29%	-1.88%	-5.64%	-20.61%	-14.89%	-28.24%	-14.77%	15.91%	2.27%
2023	-	-	-	-	-	-	-56.04%	-48.00%	-40.00%	13.66%	58.76%	98.97%
Earnings Market Reaction data beyond 3 years is for subscribers only. Unlock the full earnings market reaction history Start 7-day free trial

Subscribe to unlock 17+ years of financial data and 90+ calculated metrics

Start 7-day free trial

Subscribe to unlock 17+ years of data and 90+ calculated metrics

Start free trial

Performance and Valuation Metrics

Rows marked with a lock icon are subscribers only — subscribe to unlock 90+ calculated metrics and 17+ years of history.

Metrics	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30
Liquidity Ratios
Current Ratio	4.51	5.59	1.66	1.18	2.19	2.35	2.65	2.56	3.42	1.77	1.53	1.60
Quick Ratio	4.41	5.44	1.48	1.10	2.03	2.16	2.53	2.42	3.35	1.72	1.48	1.50
Working Capital	21.98M	28.99M	3.87M	1.76M	6.00M	6.80M	6.32M	5.63M	8.51M	3.79M	2.63M	2.48M
Leverage & Debt
Debt to Equity	0.37	0.27	3.08	281.75	1.85	1.40	1.79	4.71	2.80	-2.51	14.85	1.55
Interest Coverage TTM	-	-	-	-891,322.11	-175,084.61	-163,130.66	-150,063.81	-215,652.33	-19,097,623.00	-11,624.13	-2,940.75	-1,785.44
Debt Ratio	0.27	0.21	0.76	1.00	0.65	0.58	0.64	0.82	0.74	1.66	0.94	0.61
Efficiency & Turnover
Asset Turnover TTM	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Per Share Metrics
Diluted EPS TTM	-0.44	-0.54	-0.70	-0.67	-0.53	-0.71	-1.05	-1.09	-1.26	-1.35	-1.49	-1.54
Free Cash Flow Per Share TTM	-0.35	-0.44	-0.59	-0.35	-0.38	-0.59	-0.71	-0.66	-0.69	-0.76	-0.99	-0.88
Dividend Per Share TTM	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Growth Metrics
Net Income Growth (1Y)	66.00%	23.06%	-3.69%	-13.88%	-42.41%	-16.94%	17.61%	23.08%	33.05%	19.30%	-	-
EPS Growth (1Y)	-17.27%	-24.61%	-33.43%	-38.02%	-57.80%	-47.22%	-29.74%	-29.56%	-22.79%	-25.60%	-	-
Valuation Metrics
P/E TTM	-3.26	-2.61	-2.19	-2.29	-3.37	-2.15	-1.89	-2.59	-2.70	-1.63	-0.78	-1.43
P/B TTM	4.23	2.28	20.68	1,227.05	14.07	8.57	12.09	41.48	24.02	-6.72	32.49	10.95
Market Cap	87.54M	63.30M	49.14M	51.13M	54.54M	42.38M	43.95M	67.14M	75.93M	38.72M	15.52M	30.09M
Enterprise Value	59.95M	28.88M	40.48M	40.24M	44.40M	31.51M	34.35M	58.45M	64.36M	30.45M	8.37M	23.98M
Calculated Values
Free Cash Flow TTM	-21.46M	-19.95M	-18.84M	-11.53M	-11.57M	-16.32M	-15.70M	-15.79M	-15.42M	-13.30M	-13.07M	-12.03M
Net Debt	-27.60M	-34.41M	-8.66M	-10.89M	-10.14M	-10.86M	-9.60M	-8.69M	-11.58M	-8.27M	-7.15M	-6.10M
Per-Share and Margin
EPS TTM
Adjusted EPS TTM
Cash Flow Per Share TTM
Pretax Margin TTM
Stock Comp to Revenue TTM
Turnover Ratios and Averages
Average Assets
Average Equity
Average Inventory
Average Receivables
Average Accounts Payables
Inventory Turnover TTM
Payables Turnover TTM
Days Inventory Outstanding TTM
Days Payables Outstanding TTM
Cash Conversion Cycle TTM
Working Capital to Revenue
Deferred Revenue to Revenue
Growth Rates
Total Assets Growth (1Y)
Total Assets Growth (3Y)
Total Assets Growth (5Y)
Dividends Paid Growth (1Y)
Dividends Paid Growth (3Y)
Dividends Paid Growth (5Y)
EPS Growth (3Y)
EPS Growth (5Y)
Net Income Growth (3Y)
Net Income Growth (5Y)
Net Profit Margin Growth (1Y)
Net Profit Margin Growth (3Y)
Net Profit Margin Growth (5Y)
Net Revenue Growth (3Y)
Net Revenue Growth (5Y)
Deferred Revenue Growth (1Y)
Retained Earnings Growth (1Y)
Credit, Liquidity, Returns, Payout
Cash Ratio
Net Working Capital
Debt to EBITDA TTM
Net Debt to EBITDA TTM
Net Debt to Equity
Altman A
Altman B
Altman C
Altman D
Altman E
Altman Z-Score
ROA TTM
ROE TTM
NOPAT TTM
ROIC TTM
Effective Tax Rate TTM
Payout Ratio TTM
Dilution Ratio
Retained Earnings to Equity
Treasury Stock to Equity
Treasury Stock Change (1Y)
Accrued to Current Liabilities
NCAV
NCAV Per Share TTM
Valuation Ratios
P/CF TTM
PEG Ratio
Dividend Yield TTM
Free Cash Flow Yield TTM
EV EBITDA TTM
EV EBIT TTM
EV Revenue TTM
EV FCF TTM
Stock Compensation TTM
Adjusted Net Income TTM
Billings TTM
Total Debt
Invested Capital

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Insider Transactions

2026-06-01Purchase

Owner: Vitoc, Vlad

Title: Chief Executive Officer

Shares: 72,700

Price/Share: $1.39

Value: $101,053.00

Shares Owned: 976,121

Relationship: Director,Officer,TenPercentOwner

Ownership: Direct

2026-06-01Purchase

Owner: Gryaznov, Sergei

Title: Chief Scientific Officer

Shares: 2,000

Price/Share: $1.35

Value: $2,700.00

Shares Owned: 46,511

Relationship: Officer

Ownership: Direct

2026-06-01Purchase

Owner: Smith, Stan

Title: -

Shares: 75,000

Price/Share: $1.34

Value: $100,500.00

Shares Owned: 1,519,178

Relationship: Director

Ownership: Indirect

2025-12-22Purchase

Owner: Chaouki, Steven M

Title: -

Shares: 40,849

Price/Share: $1.22

Value: $49,835.78

Shares Owned: 151,873

Relationship: Director

Ownership: Direct

2025-12-22Purchase

Owner: Smith, Stan

Title: -

Shares: 57,189

Price/Share: $1.22

Value: $69,770.58

Shares Owned: 1,421,478

Relationship: Director

Ownership: Indirect

Filed Date	Owner	Relationship	Title	Ownership	Purchase/Sale	No. Shares	Price Per Share	Value	Shares Owned	Document Type
2026-06-01	Vitoc, Vlad	Director,Officer,TenPercentOwner	Chief Executive Officer	Direct	Purchase	72,700	1.39	$101,053.00	976,121	4
2026-06-01	Gryaznov, Sergei	Officer	Chief Scientific Officer	Direct	Purchase	2,000	1.35	$2,700.00	46,511	4
2026-06-01	Smith, Stan	Director	-	Indirect	Purchase	75,000	1.34	$100,500.00	1,519,178	4
2025-12-22	Chaouki, Steven M	Director	-	Direct	Purchase	40,849	1.22	$49,835.78	151,873	4
2025-12-22	Smith, Stan	Director	-	Indirect	Purchase	57,189	1.22	$69,770.58	1,421,478	4
2025-12-22	Louie, Ngar Yee	Director	-	Direct	Purchase	81,699	1.22	$99,672.78	1,248,888	4
2025-12-05	Smith, Stan	Director	-	Indirect	Purchase	13,740	1.20	$16,488.00	4,580	4
2025-11-28	Luput, Cristian	Director	-	Direct	Purchase	18,145	1.11	$20,140.95	437,628	4
2025-11-28	Vitoc, Vlad	Director,Officer,TenPercentOwner	Chief Executive Officer	Direct	Purchase	50,000	1.14	$57,000.00	903,421	4/A
2025-11-26	Smith, Stan	Director	-	Indirect	Purchase	15,000	1.04	$15,600.00	1,364,289	4
2025-11-25	Luput, Cristian	Director	-	Direct	Purchase	10,000	0.98	$9,800.00	399,483	4
2025-11-25	Vitoc, Vlad	Director,Officer,TenPercentOwner	Chief Executive Officer	Direct	Purchase	10,500	0.97	$10,185.00	831,421	4/A
2025-11-25	Smith, Stan	Director	-	Indirect	Purchase	15,000	0.98	$14,700.00	1,349,289	4
2025-11-24	Vitoc, Vlad	Director,Officer,TenPercentOwner	Chief Executive Officer	Direct	Purchase	10,000	0.99	$9,900.00	820,921	4
2025-10-01	Smith, Stan	Director	-	Indirect	Purchase	19,230	1.30	$24,999.00	1,324,289	4
2025-06-03	Smith, Stan	Director	-	Indirect	Purchase	33,333	1.50	$49,999.50	1,305,059	4
2025-05-08	Smith, Stan	Director	-	Indirect	Purchase	66,666	1.50	$99,999.00	1,271,726	4
2025-05-08	Guerrero, Ramiro	Director	-	Direct	Purchase	20,000	1.50	$30,000.00	588,218	4
2025-03-03	Smith, Stan	Director	-	Indirect	Purchase	25,000	1.50	$37,500.00	1,205,060	4
2025-03-03	Guerrero, Ramiro	Director	-	Direct	Purchase	33,333	1.50	$49,999.50	568,218	4
2025-02-24	Guerrero, Ramiro	Director	-	Direct	Purchase	73,333	1.50	$109,999.50	534,885	4/A
2025-02-24	Smith, Stan	Director	-	Indirect	Purchase	50,000	1.50	$75,000.00	1,180,060	4/A
2024-12-13	Smith, Stan	Director	-	Indirect	Purchase	25,000	1.87	$46,750.00	1,130,060	4
2024-12-13	Guerrero, Ramiro	Director	-	Direct	Purchase	53,418	1.87	$99,891.66	514,970	4
2024-11-01	Chaouki, Steven M	Director	-	Direct	Purchase	22,133	2.51	$55,553.83	111,024	4
2024-11-01	Smith, Stan	Director	-	Indirect	Purchase	100,000	2.51	$251,000.00	957,568	4
2024-11-01	Luput, Cristian	Director	-	Direct	Purchase	22,133	2.51	$55,553.83	389,483	4
2024-11-01	Guerrero, Ramiro	Director	-	Direct	Purchase	88,534	2.51	$222,220.34	408,134	4
2024-04-25	Smith, Stan	Director	-	Indirect	Purchase	147,492	2.03	$299,408.76	1,005,060	4
2024-04-25	Louie, Ngar Yee	Director	-	Direct	Purchase	19,665	2.03	$39,919.95	1,167,189	4
2024-03-14	Chaouki, Steven M	Director	-	Direct	Purchase	34,641	1.17	$40,529.97	88,891	4
2024-03-14	Louie, Ngar Yee	Director	-	Direct	Purchase	170,940	1.17	$199,999.80	1,147,524	4
2024-03-14	Guerrero, Ramiro	Director	-	Direct	Purchase	6,928	1.17	$8,105.76	319,600	4
2024-03-14	Luput, Cristian	Director	-	Direct	Purchase	69,282	1.17	$81,059.94	367,350	4
2024-03-14	Smith, Stan	Director	-	Indirect	Purchase	170,940	1.17	$199,999.80	857,568	4
Additional insider transactions are for subscribers only. Unlock the complete Form 4 filing history Start 7-day free trial

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Institutional Ownership

No data available for chart

2026-03-31

28.99%

Inst. Shares: 13,105,226

Shares Outstanding: 45,212,103

2025-12-31

7.80%

Inst. Shares: 2,504,194

Shares Outstanding: 32,114,608

2025-09-30

7.14%

Inst. Shares: 2,371,804

Shares Outstanding: 33,202,001

2025-06-30

7.54%

Inst. Shares: 2,283,471

Shares Outstanding: 30,300,339

2025-03-31

5.33%

Inst. Shares: 1,477,042

Shares Outstanding: 27,696,550

Date	Institutional Shares Owned	Shares Outstanding	Institutional Ownership %
2026-03-31	13,105,226	45,212,103	28.99%
2025-12-31	2,504,194	32,114,608	7.80%
2025-09-30	2,371,804	33,202,001	7.14%
2025-06-30	2,283,471	30,300,339	7.54%
2025-03-31	1,477,042	27,696,550	5.33%
2024-12-31	1,382,985	22,197,517	6.23%
2024-09-30	1,467,276	23,894,980	6.14%
2024-06-30	1,788,020	22,203,174	8.05%
2024-03-31	609,448	17,601,407	3.46%
2023-12-31	692,073	13,261,572	5.22%
2023-09-30	300,745	13,675,802	2.20%
2023-06-30	311,122	12,885,134	2.41%
Additional institutional holders are for subscribers only. Unlock the complete Form 13F ownership history Start 7-day free trial

MAIA Biotechnology, Inc. (MAIA) — SEC Financial Statements & Analysis

MAIA Biotechnology, Inc. (MAIA) is a pharmaceutical preparations company, incorporated in DE. MAIA Biotechnology, Inc. trades on NYSE as: MAIA. Based on its latest SEC filing (Form 10-Q, period ending 2026-06-30), MAIA Biotechnology, Inc. reported a Debt-to-Equity ratio of 0.37x, a Price-to-Book (P/B) ratio of 4.23x (TTM), at a market cap of $87.54M. Figures below are sourced from SEC EDGAR, as-filed.

Debt To Equity: 0.37x
P/B TTM: 4.23x
Market Cap: $87.54M

Data as of 2026-06-30 · Source: SEC EDGAR

Frequently Asked Questions

What industry is MAIA Biotechnology, Inc. in?

MAIA Biotechnology, Inc. (MAIA) operates in the Pharmaceutical Preparations industry.

What is MAIA's market cap?

MAIA Biotechnology, Inc. (MAIA) has a market capitalization of $87.54M as of 2026-06-30.

What exchange does MAIA trade on?

MAIA Biotechnology, Inc. (MAIA) trades on the NYSE.

Where is MAIA Biotechnology, Inc. incorporated?

MAIA Biotechnology, Inc. is incorporated in DE.